215 related articles for article (PubMed ID: 29275987)
21. Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.
Son M; Lee Y; Hwang H; Hyun S; Yu J
ChemMedChem; 2013 Oct; 8(10):1638-42. PubMed ID: 23894079
[TBL] [Abstract][Full Text] [Related]
22. Structure-function relationship of Val/Arg-rich peptides: effects of net charge and pro on activity.
Ma Q; Jiao W; Lv Y; Dong N; Zhu X; Shan A
Chem Biol Drug Des; 2014 Sep; 84(3):348-53. PubMed ID: 24649883
[TBL] [Abstract][Full Text] [Related]
23. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
Glukhov E; Burrows LL; Deber CM
Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
[TBL] [Abstract][Full Text] [Related]
24. Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.
Yu HY; Huang KC; Yip BS; Tu CH; Chen HL; Cheng HT; Cheng JW
Chembiochem; 2010 Nov; 11(16):2273-82. PubMed ID: 20865718
[TBL] [Abstract][Full Text] [Related]
25. Uncoupling Amphipathicity and Hydrophobicity: Role of Charge Clustering in Membrane Interactions of Cationic Antimicrobial Peptides.
He S; Stone TA; Deber CM
Biochemistry; 2021 Aug; 60(34):2586-2592. PubMed ID: 34423969
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, biophysical and functional studies of two BP100 analogues modified by a hydrophobic chain and a cyclic peptide.
Carretero GPB; Saraiva GKV; Cauz ACG; Rodrigues MA; Kiyota S; Riske KA; Dos Santos AA; Pinatto-Botelho MF; Bemquerer MP; Gueiros-Filho FJ; Chaimovich H; Schreier S; Cuccovia IM
Biochim Biophys Acta Biomembr; 2018 Aug; 1860(8):1502-1516. PubMed ID: 29750913
[TBL] [Abstract][Full Text] [Related]
27. Spectroscopic investigations of the binding mechanisms between antimicrobial peptides and membrane models of Pseudomonas aeruginosa and Klebsiella pneumoniae.
Chai H; Allen WE; Hicks RP
Bioorg Med Chem; 2014 Aug; 22(15):4210-22. PubMed ID: 24931276
[TBL] [Abstract][Full Text] [Related]
28. Rationally designed α-helical broad-spectrum antimicrobial peptides with idealized facial amphiphilicity.
Wiradharma N; Sng MY; Khan M; Ong ZY; Yang YY
Macromol Rapid Commun; 2013 Jan; 34(1):74-80. PubMed ID: 23112127
[TBL] [Abstract][Full Text] [Related]
29. Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.
Olson L; Soto AM; Knoop FC; Conlon JM
Biochem Biophys Res Commun; 2001 Nov; 288(4):1001-5. PubMed ID: 11689009
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships of piscidin 4, a piscine antimicrobial peptide.
Park NG; Silphaduang U; Moon HS; Seo JK; Corrales J; Noga EJ
Biochemistry; 2011 Apr; 50(16):3288-99. PubMed ID: 21355570
[TBL] [Abstract][Full Text] [Related]
31. Membrane interactions and biological activity of antimicrobial peptides from Australian scorpion.
Luna-Ramírez K; Sani MA; Silva-Sanchez J; Jiménez-Vargas JM; Reyna-Flores F; Winkel KD; Wright CE; Possani LD; Separovic F
Biochim Biophys Acta; 2014 Sep; 1838(9):2140-8. PubMed ID: 24200946
[TBL] [Abstract][Full Text] [Related]
32. Interaction studies of novel cell selective antimicrobial peptides with model membranes and E. coli ATCC 11775.
Joshi S; Bisht GS; Rawat DS; Kumar A; Kumar R; Maiti S; Pasha S
Biochim Biophys Acta; 2010 Oct; 1798(10):1864-75. PubMed ID: 20599694
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
[TBL] [Abstract][Full Text] [Related]
34. How do Self-Assembling Antimicrobial Lipopeptides Kill Bacteria?
Gong H; Sani MA; Hu X; Fa K; Hart JW; Liao M; Hollowell P; Carter J; Clifton LA; Campana M; Li P; King SM; Webster JRP; Maestro A; Zhu S; Separovic F; Waigh TA; Xu H; McBain AJ; Lu JR
ACS Appl Mater Interfaces; 2020 Dec; 12(50):55675-55687. PubMed ID: 33259204
[TBL] [Abstract][Full Text] [Related]
35. Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.
Yamamoto N; Tamura A
Peptides; 2010 May; 31(5):794-805. PubMed ID: 20109510
[TBL] [Abstract][Full Text] [Related]
36. Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.
Strandberg E; Zerweck J; Horn D; Pritz G; Berditsch M; Bürck J; Wadhwani P; Ulrich AS
J Pept Sci; 2015 May; 21(5):436-45. PubMed ID: 25898805
[TBL] [Abstract][Full Text] [Related]
37. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.
Saravanan R; Mohanram H; Joshi M; Domadia PN; Torres J; Ruedl C; Bhattacharjya S
Biochim Biophys Acta; 2012 Jul; 1818(7):1613-24. PubMed ID: 22464970
[TBL] [Abstract][Full Text] [Related]
38. Reversed sequence enhances antimicrobial activity of a synthetic peptide.
Gopal R; Kim YJ; Seo CH; Hahm KS; Park Y
J Pept Sci; 2011 May; 17(5):329-34. PubMed ID: 21462284
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial activity, membrane interaction and stability of the D-amino acid substituted analogs of antimicrobial peptide W3R6.
Li Y; Liu T; Liu Y; Tan Z; Ju Y; Yang Y; Dong W
J Photochem Photobiol B; 2019 Nov; 200():111645. PubMed ID: 31671371
[TBL] [Abstract][Full Text] [Related]
40. Peptide-Membrane Interaction between Targeting and Lysis.
Stutz K; Müller AT; Hiss JA; Schneider P; Blatter M; Pfeiffer B; Posselt G; Kanfer G; Kornmann B; Wrede P; Altmann KH; Wessler S; Schneider G
ACS Chem Biol; 2017 Sep; 12(9):2254-2259. PubMed ID: 28763193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
